Latest drug discovery Stories
ROCKVILLE, Md., Jan. 16, 2015 /PRNewswire/ -- CASI Pharmaceuticals, Inc.
The Clinical Data Interchange Standards Consortium (CDISC), Critical Path Institute (C-Path) and TransCelerate BioPharma Inc.
BUDAPEST, Hungary, January 15, 2015 /PRNewswire/ -- Accurately register, store and search peptides, ADC's, RNAi therapeutics and more ChemAxon [http://www.chemaxon.com/#_blank
TR-FRET is a preferred detection mode for HTS, and the availability of BellBrook Labs' new UDP assay will better serve a growing need for robust, HTS-proven glycosyltransferase assays for developing
Transparency Market Research published a new report titled "Digital Pathology Systems Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" to its
CHARLOTTESVILLE, Va., Jan. 12, 2015 /PRNewswire/ -- HemoShear, a privately held discovery stage biotechnology company, announced today a multi-year platform collaboration with Pfizer Inc.
-- First Observation of Dose Limiting Toxicity Signals VAL-083's Potential Advancement Toward Registration Directed Clinical Trials in Refractory Glioblastoma -- VANCOUVER, British Columbia
AMRI to purchase Glasgow, UK and West Lafayette, Indiana, U.S.A. sites GREENWICH, Conn., Jan. 9, 2015 /PRNewswire/ -- Dr.
Selexis SA announced today the first therapeutic biologic generated with the Selexis SUREtechnology Platform™ has been approved for market. Geneva, Switzerland
BETHESDA, Md., Jan. 8, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a U.S.
- Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.